Correlation Between Pharvaris and Molecular Partners
Can any of the company-specific risk be diversified away by investing in both Pharvaris and Molecular Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharvaris and Molecular Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharvaris BV and Molecular Partners AG, you can compare the effects of market volatilities on Pharvaris and Molecular Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharvaris with a short position of Molecular Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharvaris and Molecular Partners.
Diversification Opportunities for Pharvaris and Molecular Partners
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Pharvaris and Molecular is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Pharvaris BV and Molecular Partners AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Partners and Pharvaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharvaris BV are associated (or correlated) with Molecular Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Partners has no effect on the direction of Pharvaris i.e., Pharvaris and Molecular Partners go up and down completely randomly.
Pair Corralation between Pharvaris and Molecular Partners
Given the investment horizon of 90 days Pharvaris BV is expected to generate 2.66 times more return on investment than Molecular Partners. However, Pharvaris is 2.66 times more volatile than Molecular Partners AG. It trades about 0.1 of its potential returns per unit of risk. Molecular Partners AG is currently generating about 0.07 per unit of risk. If you would invest 1,760 in Pharvaris BV on May 1, 2025 and sell it today you would earn a total of 201.00 from holding Pharvaris BV or generate 11.42% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.45% |
| Values | Daily Returns |
Pharvaris BV vs. Molecular Partners AG
Performance |
| Timeline |
| Pharvaris BV |
| Molecular Partners |
Pharvaris and Molecular Partners Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pharvaris and Molecular Partners
The main advantage of trading using opposite Pharvaris and Molecular Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharvaris position performs unexpectedly, Molecular Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Partners will offset losses from the drop in Molecular Partners' long position.| Pharvaris vs. Molecular Partners AG | Pharvaris vs. Pmv Pharmaceuticals | Pharvaris vs. Edgewise Therapeutics | Pharvaris vs. Rallybio Corp |
| Molecular Partners vs. Climb Bio | Molecular Partners vs. Edgewise Therapeutics | Molecular Partners vs. Monte Rosa Therapeutics | Molecular Partners vs. Century Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |